BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26733171)

  • 1. Sphingosine kinase 2 promotes colorectal cancer cell proliferation and invasion by enhancing MYC expression.
    Zhang L; Liu X; Zuo Z; Hao C; Ma Y
    Tumour Biol; 2016 Jun; 37(6):8455-60. PubMed ID: 26733171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SphK1 promotes tumor cell migration and invasion in colorectal cancer.
    Long J; Xie Y; Yin J; Lu W; Fang S
    Tumour Biol; 2016 May; 37(5):6831-6. PubMed ID: 26662312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
    Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
    Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
    Cui W; Li SY; Du JF; Zhu ZM; An P
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):393-400. PubMed ID: 22893466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Sphk2 suppresses bladder cancer progression.
    Sun E; Zhang W; Wang L; Wang A; Ma C; Lei M; Zhou X; Sun Y; Lu B; Liu L; Han R
    Tumour Biol; 2016 Jan; 37(1):473-8. PubMed ID: 26224479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
    Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
    Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer.
    Liu W; Ning J; Li C; Hu J; Meng Q; Lu H; Cai L
    Tumour Biol; 2016 May; 37(5):6331-6. PubMed ID: 26628299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
    PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
    Li Y; Dong M; Kong F; Zhou J
    Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
    Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
    Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.
    Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K
    Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.
    Miao W; Wang Y
    J Proteome Res; 2019 May; 18(5):2279-2286. PubMed ID: 30908912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity.
    Li MY; Zhu M; Feng F; Cai FY; Fan KC; Jiang H; Wang ZQ; Linghu EQ
    Genet Mol Res; 2014 Apr; 13(3):6981-94. PubMed ID: 24782214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
    Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.